Stoboclo® and Osenvelt® (CT-P41) received Health Canada Notice of Compliance for all indications referencing Prolia® and ...

Genflow Strengthens Global IP Portfolio with China Patent Examination Filing for SIRT6 Variants in NASH LONDON, UK / ACCESS Newswire / September 19, 2025 / Genflow Biosciences Plc ...

PBIRx, Inc., a national leader in pharmacy benefit consulting and auditing, is proud to announce exciting updates reflecting ...

Nextern today announced the appointment of John Hastings as Chief Executive Officer, effective September 29, 2025.Hastings ...

With 18 million YouTube/social media impressions since July 1, podcast builds community with families of people searching for ...

Celltrion’s Omlyclo™, the first and only omalizumab biosimilar in Europe, will be commercially available starting in Norway, ...

Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health – and official partner of FC ...

Real Chemistry, a leader in AI-driven insights and marketing communications exclusively for the healthcare sector, announces ...

Lazard announced today that Dr. Geoffrey Porges has joined the firm as Managing Director in the Healthcare Advisory Group, ...

Enhances Strategic Focus and Clarity to Capital AllocationIRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) ...

Rethink Impact leads investment round as company targets expansion to 30+ states by end of 2026 WASHINGTON, DC / ACCESS ...

Immuto Scientific unveils collaboration with Daiichi Sankyo to identify cancer‑specific cell‑surface targetsMADISON, Wis. & ...